Search Results - "Kepe, V"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3

    Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease by BOXER, A. L, RABINOVICI, G. D, SMALL, G. W, BARRIO, J. R, JAGUST, W, MILLER, B. L, KEPE, V, GOLDMAN, J, FURST, A. J, HUANG, S.-C, BAKER, S. L, O'NEIL, J. P, CHUI, H, GESCHWIND, M. D

    Published in Neurology (17-07-2007)
    “…To compare the in vivo uptake of two amyloid-binding PET agents, PIB and FDDNP, in human subjects with a prion protein (PrP) gene (PRNP) mutation that produces…”
    Get full text
    Journal Article
  4. 4

    FDDNP binding using MR derived cortical surface maps by Protas, H.D., Huang, S.-C., Kepe, V., Hayashi, K., Klunder, A., Braskie, M.N., Ercoli, L., Bookheimer, S., Thompson, P.M., Small, G.W., Barrio, J.R.

    Published in NeuroImage (Orlando, Fla.) (01-01-2010)
    “…To assess quantitatively the cortical pattern profile of regional FDDNP binding to beta-amyloid and neurofibrillary tangles on MR derived cortical maps, FDDNP…”
    Get full text
    Journal Article
  5. 5

    Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging by Ercoli, L. M., Small, G. W., Siddarth, P., Kepe, V., Huang, S.-C., Miller, K. J., Lavretsky, H., Bookheimer, S. Y., Barrio, J. R., Silverman, D. H. S.

    “…Background In a previous study, positron emission tomography (PET) with 2‐(1‐{6‐[(2‐[F‐18]fluoroethyl)(methyl)amino]‐2‐naphthyl}ethylidene)malononitrile…”
    Get full text
    Journal Article
  6. 6

    Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment by Barrio, J. R., Kepe, V., Satyamurthy, N., Huang, S. C., Small, G.

    “…Objectives : Establish new approaches for early diagnosis of dementia, based on imaging amyloid and tau pathology, cell losses and neuronal function, in…”
    Get full text
    Journal Article Conference Proceeding
  7. 7
  8. 8
  9. 9

    Correlation of Cortical Thickness Within the Medial Temporal Lobe to PET Measures of Brain Amyloid and Tau by Burggren, AC, Martin-Harris, L, Suthana, NS, Donix, M, Ekstrom, AD, Jones, M, Renner, B, Kepe, V, Huang, S-C, Barrio, J, Ercoli, LM, Miller, KJ, Siddarth, P, Small, GW, Bookheimer, SY

    Published in NeuroImage (Orlando, Fla.) (01-07-2009)
    “…Introduction Our lab has shown differences in cortical thickness in medial temporal lobe (MTL) subregions in cognitively intact apolipoprotein E-4 (APOE-4)…”
    Get full text
    Journal Article
  10. 10

    Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology by Shoghi-Jadid, Kooresh, Barrio, Jorge R, Kepe, Vladimir, Huang, Sung-Cheng

    Published in Molecular imaging and biology (01-05-2006)
    “…Amyloid plaques are highly heterogeneous in content, size, density, and macromolecular crowding, as they are composed of masses of fibrils and other cellular…”
    Get full text
    Journal Article
  11. 11

    In vivo brain imaging of tangle burden in humans by Small, Gary W, Agdeppa, Eric D, Kepe, Vladimir, Satyamurthy, Nagichettiar, Huang, Sung-Cheng, Barrio, Jorge R

    Published in Journal of molecular neuroscience (01-12-2002)
    “…Cerebral neurofibrillary tangles (NFTs) accumulate in a predictable sequence decades before the clinical symptoms of Alzheimer's disease emerge, and the degree…”
    Get full text
    Journal Article
  12. 12

    Abnormal protein aggregation in the brains of long-term surviving HIV patients in the HAART era by Achim, CL, Barrio, J R, Kepe, V, Everall, I P, Masliah, E, Smid, A, Cherner, M, Taylor, MJ, Vinters, H V, Pomakian, J, Satyamurthy, N, von Jaeger, R, Small, G W, Grant, I

    Published in Journal of neurovirology (01-01-2007)
    “…Background: Human immunodeficiency virus (HIV) positive patients under highly active anti-retroviral therapy (HAART) regimens show a markedly improved general…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Evaluation of two graphical approaches for regional analysis and parametric mapping of dynamic [18F]FDDNP PET studies by Koon-Pong Wong, Sung-Cheng Huang, Kepe, V., Small, G.W., Barrio, J.R.

    “…Positron emission tomography (PET) with 2-(1-{6-[(2-[ 18 F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malo-nonitrile ([ 18 F]FDDNP) has been used for in…”
    Get full text
    Conference Proceeding
  15. 15

    Comparison of simplified methods for quantitative analysis of [18F]FDDNP PET data by Koon-Pong Wong, Kepe, V., Small, G.W., Satyamurthy, N., Barrio, J.R., Sung-Cheng Huang

    “…Positron emission tomography (PET) with 2-(1-{6- [(2-[ 18 F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malo-nonitrile ([ 18 F]FDDNP) has been used for in…”
    Get full text
    Conference Proceeding
  16. 16

    Movement correction of [18F]FDDNP PET studies for brain amyloid imaging by Koon-Pong Wong, Wardak, M., Weber Shao, Zicong Zhou, Dahlbom, M., Smid, L., Truong, D., Kepe, V., Small, G.W., Barrio, J.R., Sung-Cheng Huang

    “…2-(l-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naph- thyl}ethylidene)malononitrile ([ 18 F]FDDNP) PET studies for imaging neuronal concentration of beta-amyloid…”
    Get full text
    Conference Proceeding
  17. 17
  18. 18
  19. 19